Back to search
Major Depression Moderate
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depression Moderate trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depression Moderate trials you may qualify forThis is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if ne…
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner…
This study aims to assess the impact of dupilumab on the mental health and quality of life of moderate-to-severe Atopic Dermatitis (AD) patients. The study will…
The indication of attention-deficit/hyperactivity disorder (ADHD) to be examined often occurs with other psychiatric disorders, and the majority of adults with…
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monoth…
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner…
Depression is a leading cause of disability worldwide and poses a large economic burden in the UK. There is evidence that exercise is beneficial in the manageme…
The aim of this study is to explore the effectiveness and safety of different doses of neural regulation under the guidance of pBFS technology in improving symp…
This work will extend and apply methods for modeling heterogeneous treatment effects when multiple studies are available, with a particular focus on the complex…